A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden

Overview of attention for article published in Frontiers in immunology, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 106 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice

Article in International Immunopharmacology (June 2024)

LaSap vaccine: Immunotherapy and immunochemotherapy associated with allopurinol in dogs naturally infected with Leishmania infantum

Article in Parasite Immunology (February 2024)

Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis

Article in Pathogens (February 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.